Monitoring drug effectiveness in kala-azar in Bihar, India: Cost and feasibility of periodic random surveys vs. a health service-based reporting system

Tropical Medicine and International Health

Volumn 16, Issue 9, 2011, Pages 1159-1166

  Malaviya, P ^a   Singh, R P ^a   Singh, S P ^a   Hasker, E ^b   Ostyn, B ^b   Shankar, R ^a   Boelaert, M ^b   Sundar, S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Drug effectiveness; Drug monitoring; Patient follow up; Public health system; Recording and reporting; Supervised treatment; Visceral leishmaniasis

Indexed keywords

COHORT ANALYSIS; COST-BENEFIT ANALYSIS; DISEASE TREATMENT; DRUG; FIELDWORK; HEALTH SURVEY; HEALTH WORKER; LEISHMANIASIS; MONITORING; PRIMARY HEALTH CARE; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; TUBERCULOSIS;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL SUPERVISION; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MONITORING; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH CENTER; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INDIA; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL RECORD; OUTCOME ASSESSMENT; PATIENT; PHYSICIAN; PRIMARY HEALTH CARE; QUESTIONNAIRE; RETROSPECTIVE STUDY; TUBERCULOSIS; VISCERAL LEISHMANIASIS;

ADULT; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG MONITORING; FEMALE; HEALTH CARE COSTS; HUMANS; INDIA; LEISHMANIASIS, VISCERAL; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE;

BIHAR; INDIA; MUZAFFARNAGAR; UTTAR PRADESH;

NASO HEXACANTHUS;

EID: 79961173344     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02803.x     Document Type: Article

References (10)

1. Addy M & Nandy A (1992) Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?. Bulletin of the World Health Organization 70, 341-346.
2. Chappuis F, Sundar S, Hailu A et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews. Microbiology 5, 873-82.
3. Hasker E, Singh SP, Malaviya P et al. (2010) Management of visceral leishmaniasis in rural primary health care services in Bihar, India. VL Supplement, TMIH 15 (Suppl. 2), 55-62.
4. Styblo K (1976) Surveillance of tuberculosis. International Journal of Epidemiology 5, 63-68.
5. Styblo K & Bumgarner R (1991) Tuberculosis can be controlled with existing technologies: evidence. Tuberculosis Surveillance Research Unit Progress Report 2, 60-72.
6. Sundar S, Pai K, Kumar R et al. (2001) Resistance to treatment in Kala-azar: speciation of isolates from northeast India. American Journal of Tropical Medicine and Hygiene 65, 193-196.
7. van Griensven J, Balasegaram M, Meheus F et al. (2010) Combination therapy for visceral leishmaniasis. Lancet infectious diseases 10, 184-194.
8. Veen J, Raviglione M, Rieder HL et al. (1998) Standardized tuberculosis treatment outcome monitoring in Europe. European Respiratory Journal 12, 505-510.
9. World Health Organization (1990) Control of the leishmaniases. Report of a WHO Expert Committee. World Health Organization Technical Report Series 793, 1-158.
10. World Health Organization, Regional office for South-East Asia (2005) Regional strategic framework for elimination of Kala-azar from the South-East Asia region (2005-2015). [Online] (Accessed 23 March 2010).